New Research Links Cannabis Use to Significantly Higher Cardiovascular Risk

As cannabis legalization expands across many regions, its perceived safety has often outpaced scientific understanding of its long-term health impacts. However, two significant new studies presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and published in JACC Advances are adding to a growing body of evidence, suggesting that cannabis use is associated with a substantially higher risk of serious cardiovascular events. These findings are particularly notable as they highlight risks even among younger adults who are otherwise considered healthy.

What happened

The research involved a retrospective study of over 4.6 million individuals and a meta-analysis pooling data from 12 previously published studies, encompassing over 75 million people. The retrospective study, utilizing the TriNetX global health research network, focused on cannabis users younger than 50 who were free of significant cardiovascular comorbidities at baseline, including healthy blood pressure and LDL cholesterol levels, and no diabetes or tobacco use. Over an average follow-up of three years, these cannabis users faced more than a sixfold increased risk of heart attack, a fourfold increased risk of ischemic stroke, a twofold increased risk of heart failure, and a threefold increased risk of cardiovascular death, heart attack, or stroke.

The meta-analysis, the largest pooled study to date on heart attacks and cannabis use, further solidified these findings. It revealed that active cannabis users were 1.5 times (or 50%) more likely to suffer a heart attack compared to non-users. While individual studies within the meta-analysis showed some variability, the combined data presented a significant positive association. The average age of participants in the studies that provided age data was 41, indicating that the elevated risks are present in a relatively young population.

Why it matters

These findings carry significant implications for public health, clinical practice, and policy-making, especially as cannabis use becomes more widespread and socially accepted. The fact that these risks are observed in younger, otherwise healthy adults challenges the notion that cannabis is benign for the cardiovascular system, particularly when consumed without other major risk factors like tobacco. For developers and builders, understanding these health risks is crucial for informed personal health decisions and for recognizing the broader societal impact of changing drug policies.

The research underscores the importance for healthcare providers to routinely inquire about cannabis use during patient assessments, much like they would for tobacco or alcohol. At a policy level, the data suggests that public health campaigns should include clear warnings about the cardiovascular risks associated with cannabis, ensuring consumers are fully aware of potential health consequences beyond what is commonly discussed.

How to think about it

For those in the developer and builder communities, these studies serve as a critical update to our understanding of cannabis's health profile. While the exact mechanisms are still under investigation, the consistent and significant association with adverse cardiovascular events, even in healthy young adults, warrants a cautious approach. It's important to view these findings as part of a larger risk assessment when considering cannabis use. Rather than dismissing the data due to limitations, it's more productive to integrate this information into a holistic understanding of health and wellness, recognizing that all substances carry potential risks. Engage with your healthcare provider to discuss personal risk factors and make informed choices.

FAQ